Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.51 |
| ▸ | ESR1 | P03372 | 3/20 | 0.49 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.49 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.40 |
| ▸ | LNPEP | Q9UIQ6 | 2/20 | 0.39 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.39 |
| ▸ | DPP4 | P27487 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL421632 | 0.86 | TAAR1 (0.53) | SLC7A5ESR1ESR2TAAR1SLC6A2 | |
| SCHEMBL421687 | 0.86 | ALPI (0.51) | SLC7A5TAAR1SLC6A2 | |
| SCHEMBL422021 | 0.84 | KDM4E (0.55) | SLC7A5ESR1SLC6A2 | |
| SCHEMBL2603687 | 0.76 | SLC7A5 (0.71) | SLC7A5ESR1ESR2TAAR1SLC6A2 | |
| SCHEMBL12285673 | 0.76 | SLC7A5 (0.71) | SLC7A5ESR1ESR2TAAR1SLC6A2 | |
| SCHEMBL8279093 | 0.76 | SLC7A5 (0.71) | SLC7A5ESR1ESR2TAAR1SLC6A2 | |
| Tyrosine SCHEMBL1356958 | 0.73 | SLC7A5 (0.86) | SLC7A5TAAR1SLC6A2 | |
| Tyrosine SCHEMBL1356957 | 0.73 | SLC7A5 (0.86) | SLC7A5TAAR1SLC6A2 | |
| SCHEMBL321221 | 0.72 | SLC7A5 (0.61) | SLC7A5ESR1ESR2TAAR1SLC6A2 | |
| SCHEMBL4145000 | 0.72 | SLC7A5 (0.56) | SLC7A5ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120060856-A1 | Cosmetic Composition and Reshaping Method for Keratinic Fibers | HENKEL AG & CO. KGAA (DE) | 2012-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120060856-A1 | Cosmetic Composition and Reshaping Method for Keratinic Fibers | H1-0, H1-3, H1-2 | SLC7A5 3501/4885ESR1 3905/4885ESR2 2107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.